have been demonstrated in several models associated with a variety of disorders. Our recent studies have shown that SFN protects against ethanol-induced oxidative stress and apoptosis in neural crest cells (NCCs), an ethanolsensitive cell population implicated in Fetal Alcohol Spectrum Disorders (FASD). This study is designed to test the hypothesis that SFN can prevent ethanol-induced apoptosis in NCCs by inhibiting HDAC and increasing histone acetylation at the Bcl-2 promoter. We found that exposure to 50 mM ethanol resulted in a significant increase in HDAC activities in NCCs. Treatment with SFN decreased the activities of HDAC in ethanol-exposed NCCs. We also found that SFN treatment significantly increased the expression of acetyl-histone H3 in NCCs treated with ethanol. ChIP-qPCR assay revealed that ethanol exposure significantly decreased acetyl-histone H3 binding to the Bcl-2 promoter while supplementing with SFN reversed the ethanol-induced reduction in acetylhistone H3 binding to the Bcl-2 promoter. In addition, SFN treatment restored the expression of Bcl-2 in ethanolexposed NCCs and diminished ethanol-induced apoptosis in NCCs. Treatment with SFN also significantly diminished apoptosis in mouse embryos exposed to ethanol in vivo. These results demonstrate that SFN can epigenetically restore the expression of Bcl-2 and attenuate ethanol-induced apoptosis by increasing histone acetylation at the Bcl-2 promoter and suggest that SFN may prevent FASD through epigenetic regulation of the expression of anti-apoptotic genes.
Introduction
Prenatal alcohol exposure can cause a range of structural and functional birth defects, which are defined as Fetal Alcohol Spectrum Disorders (FASD) (Sokol et al., 2003; Kodituwakku, 2007) . It has been estimated that the prevalence of FASD in the US general population range from 0.2 to 7 per 1000 children (May et al., 2009) . Studies have demonstrated that one of the major mechanisms underlying ethanolinduced teratogenesis is excessive cell death in the selective cell population, including neural crest cells (NCCs), which are progenitor cells that can give rise to various cell types (Dunty et al., 2001; Hall, 2008; Sun et al., 2014a; Chen et al., 2013) . Excessive apoptosis in NCCs has been demonstrated to significantly contribute to ethanol-induced embryo abnormalities that are phenotypic characteristics of FASD (Kotch and Sulik, 1992; Cartwright and Smith, 1995) .
Studies from our laboratory and others have shown that multiple signaling pathways are involved in ethanol-induced apoptosis, including Seven in absentia homolog1 (Siah1) (Sun et al., 2014b; Yuan et al., 2016) ; p53 pathways (Yuan et al., 2016; Jana et al., 2010) , MAPK signaling (Morio et al., 2013) and Bcl-2 family (Hong et al., 2002) . It has been reported that ethanol exposure reduced cortical Bcl-2 expression (Mooney and Miller, 2001) and that the induction of Bcl-2 by elevated interleukin-6 (IL-6) or over-expression of Bcl-2 by using Bcl-2 fusion protein can prevent ethanol-induced apoptosis or toxicity (Hong et al., 2002; Balan et al., 2010) . However, the molecular mechanisms underlying ethanol-induced apoptosis in NCCs remain to be defined. Recent studies from our laboratory have demonstrated that Nrf2 signaling is involved in ethanol-induced apoptosis in NCCs and that ethanol-induced apoptosis in NCCs can be attenuated by sulforaphane (SFN) (Chen et al., 2013; Dong et al., 2008) .
SFN is a chemical that is abundant in cruciferous vegetables, including broccoli, cabbage, and cauliflower (Keum et al., 2005) . SFN shows diverse therapeutic actions in cancer (Clarke et al., 2008; Lenzi et al., 2014) neurodegenerative disorders (Tarozzi et al., 2013) , autism spectrum disorders (Singh et al., 2014) , leukemia , and disorders of the immune system (Geisel et al., 2014) . Its cytoprotective properties have also been demonstrated in several models associated with a variety of disorders, including focal cerebral ischemia (Zhao et al., 2006 ), brain inflammation (Innamorato et al., 2008) , nephrotoxicity (Yoon et al., 2008) and hepatotoxicity (Baek et al., 2008) . It has been reported that SFN can activate Nrf2 pathway (Kim et al., 2008) , suppress the activation of NF-kappaB (Song et al., 2009) , and enhance the proteasome activities (Kwak et al., 2007; Gan et al., 2010) . More recently, it was discovered that SFN can regulate gene expression through epigenetic mechanisms, specifically by inhibiting the activities of histone deacetylase (HDAC) Ho et al., 2009) .
Epigenetic regulation, including DNA methylation and histone modifications, play a critical role in the regulation of gene expression (Cedar and Bergman, 2009 ). HDACs are a class of enzymes that remove acetyl groups on a histone and regulate the acetylation of histone together with histone acetyltransferases (HAT) (Grunstein, 1997) . Recent studies have shown that the inhibition of HDAC activity has been implicated in the treatment of cancer and other disorders (Marks et al., 2001; Bonfils et al., 2008) . Histone acetylation affects the expression of the genes involved in different pathways, including apoptosis (Grunstein, 1997; Strahl and Allis, 2000; Struhl, 1998) . Acetylation of histone H2B and hypoacetylation of histone H4 are all involved in apoptosis (Fullgrabe et al., 2010; van Bavel et al., 2009) . Given the established importance of apoptosis in NCCs in the pathogenesis of FASD, the role of epigenetic regulation of apoptosis in FASD and the potential of SFN in preventing ethanol-induced apoptosis and teratogenesis deserves to be explored.
The current study, using an NCC cell line, JoMa 1.3 cells, and a mouse FASD model, was designed to test the hypothesis that SFN can prevent ethanol-induced apoptosis in NCCs and mouse embryos by inhibiting HDAC and increasing histone acetylation at the Bcl-2 promoter. For this study, we first determined the effects of ethanol and SFN on the activity of HDAC in NCCs. We next tested whether the increase in the activity of HDAC in ethanol-exposed NCCs will result in reduced acetylation of histone H3 and whether treatment with SFN can increase the levels of acetylated histone H3 in NCCs. We have also tested whether SFN can reverse the ethanol-induced reduction in acetyl-histone H3 binding to the Bcl-2 promoter, restore the expression of Bcl-2 and attenuate ethanol-induced apoptosis in NCCs and mouse embryos. We found that SFN can epigenetically restore the expression of Bcl-2 and attenuate ethanol-induced apoptosis in NCCs by increasing histone acetylation at the Bcl-2 promoter. Treatment with SFN also significantly diminished apoptosis in mouse embryos exposed to ethanol in vivo. These results suggest that SFN may prevent FASD through epigenetic regulation of the expression of anti-apoptotic genes.
Materials and methods

Cell culture and treatment
NCCs (JoMa1.3 cells) were cultured on cell culture dishes coated with fibronectin as previously described (Sun et al., 2014b) . NCCs were pre-treated with or without 1 μM SFN (LKT Laboratories, St. Paul, MN) for 24 h. The cells pre-treated without SFN were exposed to 50 mM ethanol alone for 24 h. The cells pre-treated with SFN were followed by concurrent exposure to SFN and ethanol for additional 24 h. The stable ethanol level was kept by placing the cell culture dishes in a plastic container containing 50 mM ethanol in distilled water (Chen et al., 2013) .
Animal care and treatment
C57BL/6 J mice (Jackson Laboratory, Bar Harbor, ME) were mated for 2 h early in the light cycle. The time of vaginal plug detection was considered 0 days, 0 h of gestation (GD0:0). Pregnant mice in the experimental groups were given an intraperitoneal (i.p.) injection of SFN at a dosage of 40 mg/kg maternal body weight or PBS on GD 8:12 and then were administered two i.p. doses of ethanol at a dosage of 1.9 g/kg maternal body weight on GD 9:0 and GD 9:4. Control mice were injected with PBS according to the above regimen. Pregnant females were killed by cervical dislocation on GD 9:12 and the embryos were collected for protein preparation. All protocols used in this study were approved by the University of Louisville Institutional Animal Care and Use Committee.
Nuclear extraction and HDAC activity assay
Nuclear extracts were isolated from control and treated NCCs by using the EpiQuik Nuclear Extraction Kit (Epigentek, Brooklyn, NY), following the manufacturer's instructions. The protein concentration of nuclear extracts was measured by BCA Protein Assay Reagent (Pierce, Rockford, IL). Total HDAC activity was measured using the Fluor-deLys® HDAC Fluorometric Activity Assay Kit (Enzo Life Sciences, Farmingdale, NY). In brief, 10 μg (3-5 μl) of nuclear extracts and 20-22 μl of assay buffer were added to each well. Then the diluted substrates (25 μl) were added to each well and incubated for 30 min at room temperature. The reaction was stopped by the addition of the assay developer. After incubation with the assay developer for 15 min at room temperature, the activity of HDAC were determined using a multi-mode microplate reader (Molecular Devices, Sunnyvale, CA) with an excitation wavelength of 360 nm and an emission wavelength of 460 nm.
Quantitative real-time PCR analysis
Total RNAs were isolated from NCCs treated with SFN or ethanol using the QIAGEN RNeasy Mini Kit (Qiagen, Hilden, Germany), according to the manufacturer's instructions. The quantitative real-time PCR was performed on a Rotor-Gene Q real-time thermal cycler (Qiagen, Hilden, Germany) with the FastStart Universal SYBR Green Master qPCR kit (Roche, Mannheim, Germany). The following primer pairs were used: Bcl-2: forward: 5′-GAACTGGGGGAGGATTGTGG-3′; reverse: 5′-GCATGCTGGGGCCATATAGT-3′; β-actin: forward: 5′-AGCCTTCCTTCTTGGGTATGGAATC-3′; reverse: 5′-GGAGCAATG ATCTTGATCTTCATGG-3′. The relative changes in gene expression were analyzed by comparing threshold cycle number of Bcl-2 and a reference β-actin mRNA as described previously (Chen et al., 2013) .
Western blotting
Western blotting was performed as described previously (Chen et al., 2013) . The protein levels of Acetyl-Histone H3, Histone H3, Histone 2B, Bcl-2, and cleaved caspase-3 were analyzed with the following antibodies, respectively: Acetyl-Histone H3 (Millipore, Temecula, CA), Histone H3 (Millipore, Temecula, CA), Histone 2B (Santa Cruz, Santa Cruz, CA), Bcl-2 (Cell Signaling, Beverly, MA), and Cleaved caspase-3 (Asp175) Rabbit pAb (Cell Signaling, Beverly, MA). The membranes were developed on a Molecular Imager ChemiDoc XRS + System (Bio-Rad, Hercules, CA) and the intensity of the protein band was analyzed by ImageJ software (1.46b, National Institutes of Health, USA). All Western blot analyses were performed in triplicate.
ChIP-qPCR analysis of acetyl-histone H3 binding to Bcl-2 promoter
Chromatin preparation and immunoprecipitation from NCCs were carried out with Acetyl-Histone H3 Immunoprecipitation (ChIP) Assay Kit (Millipore, Temecula, CA), according to the manufacturer's protocol. In brief, NCCs were collected from different groups and crosslinked with 1% formaldehyde for 10 min at 37°C. Cross-linking was blocked, and the cells were washed, scraped into conical tubes and lysed in SDS lysis buffer. The lysates were sonicated to shear DNA to the length between 200 and 1000 base pairs with 5 sets of 10-second pulses using a QSonica Q125 sonicator (QSonica, Newtown, CT). This standardized sonicated condition was used in all samples. After centrifugation and dilution with ChIP dilution buffer, 1% of the diluted cell supernatant (around 20 μL) was reserved as an input sample. The supernatant was pre-cleared with Salmon Sperm DNA/protein A agarose beads for 1 h at 4°C with agitation. The antibody against acetyl-Histone H3 (1 μg) (Millipore, Temecula, CA) was then added to the supernatant and incubated overnight at 4°C with rotation, and then incubated with 60 μl Salmon Sperm DNA/protein A agarose beads for 1 h at 4°C. The Immunoprecipitated complex was then washed and eluted. The histone-DNA crosslinks were reversed, and DNA was purified for Real-time PCR assay. Quantitative real-time PCR was performed on bound and input DNAs with the following primers for Bcl-2: forward: 5′-AAAGAGCT GGATTATAACTA-3′; reverse: 5′-CTTGCGCCATCCTTCCCCGAAAA-3′.
Analysis of apoptosis
Apoptosis was determined by the analysis of cleavage of caspase-3 and its activity, and TUNEL assay as previously described (Sun et al., 2014b) . Caspase-3 cleavage was determined by Western blot. Caspase activity was determined by using Caspase-Glo® 3/7 Assay Systems (Promega, Madison, WI) according to the manufacturer's protocol. TUNEL assay was performed by using a TiterTACS In Situ Detection Kit (Trevigen, MD, USA), following the manufacturer's protocols.
Statistical analysis
Statistical analyses were performed as previously described (Chen et al., 2013) by using GraphPad Prism software (GraphPad Software, San Diego, CA, USA). All data were expressed as means ± SD of three separate experiments. The difference between groups was compared by One-way ANOVA. Differences between groups were considered significant at p < 0.05.
Results
SFN treatment significantly decreased the activity of HDAC in ethanolexposed NCCs
To determine the effects of ethanol and SFN on the activity of HDAC in NCCs, cells were treated with 1 μM SFN alone for 24 h, followed by 24 h of concurrent exposure to SFN and 50 mM ethanol. As shown in Fig. 1 , ethanol exposure resulted in a significant increase in the activity of HDAC in NCCs. Treatment with SFN significantly reduced the ethanol-induced increase in the activity of HDAC in NCCs, demonstrating that SFN can reverse the effects of ethanol on the activity of HDAC.
3.2. Treatment with SFN resulted in a significant increase in the levels of acetylated histone H3 in NCCs exposed to ethanol
The acetylation of histone H3, which is tightly controlled by HDAC and HAT, plays a critical role in regulating gene expression (Bartova et al., 2005) . We next determine whether the increase in the activity of HDAC in ethanol-exposed NCCs will result in a reduced acetylation of histone H3 and whether treatment with SFN can increase the levels of acetylated histone H3 in NCCs exposed to ethanol. Western blot analysis revealed that exposure to ethanol or SFN alone or in combination did not result in a significant change in the total protein expression of histone H3. However, ethanol exposure significantly decreased the levels of acetylated histone H3 in NCCs. Co-treatment with SFN significantly increased the acetylation of histone H3 in ethanol-exposed NCCs (Fig. 2) . These results indicate that the inhibition of HDAC activity by SFN can reverse the ethanol-induced reduction in the levels of acetylated histone H3 in NCCs.
3.3. Supplement with SFN reversed the ethanol-induced reduction in acetylhistone H3 binding to the Bcl-2 promoter
We next determine whether ethanol exposure can decrease the acetyl-histone H3 binding to the promoter of the anti-apoptotic gene, Bcl-2 and whether SFN treatment can increase the binding of acetylated histone H3 to the promoter of Bcl-2. Using ChIP-qPCR assay, we found that ethanol exposure significantly decreased acetyl-histone H3 binding to the Bcl-2 promoter, while supplementing with SFN greatly reversed the ethanol-induced reduction in acetyl-histone H3 binding to the Bcl-2 promoter (Fig. 3) , suggesting that SFN treatment can increase the promoter-associated histone acetylation in Bcl-2.
SFN treatment restored the mRNA and protein expression of Bcl-2 in NCCs treated with ethanol
To determine whether the ethanol-induced reduction in acetyl-histone H3 binding to the promoter of Bcl-2 resulted in a decrease in Bcl-2 transcriptional activation and whether SFN can induce a robust transcriptional activation of Bcl-2 by reversing the ethanol-induced reduction in acetyl-histone H3 binding to Bcl-2 promoter, the mRNA and Fig. 1 . Effects of SFN on HDAC activity in ethanol-exposed neural crest cells. NCCs were exposed to 50 mM ethanol alone or pretreated with 1 μM SFN for 24 h, followed by 24 h of concurrent exposure to SFN and 50 mM ethanol. The nuclear was extracted, and HDAC activity was measured with Fluor-de-Lys® HDAC fluorometric activity assay kit as described in Methods. Data are expressed as fold change over control and represent the mean ± SD of three separate experiments. *p < 0.05 vs. control; #p < 0.05 vs. ethanol.
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Experimental Neurology 300 (2018) [60] [61] [62] [63] [64] [65] [66] protein expressions of Bcl-2 were determined in NCCs exposed to ethanol alone or in combination with SFN. We found that ethanol exposure significantly decreased the mRNA expression of Bcl-2 in NCCs. Co-treatment with SFN significantly attenuated the ethanol-induced reduction in Bcl-2 mRNA expression (Fig. 4A) . SFN treatment also significantly increased the protein expression of Bcl-2 in ethanol-exposed NCCs, demonstrating that the decrease in Bcl-2 expression can be restored by SFN in ethanol-exposed NCCs (Fig. 4B) .
Epigenetically restoring the expression of Bcl-2 by SFN significantly diminished ethanol-induced apoptosis in NCCs
To determine whether epigenetically restoring the expression of Bcl-2 by SFN in NCCs can diminish ethanol-induced apoptosis, apoptosis was determined in NCCs exposed to ethanol or co-treated with ethanol and SFN. We found that ethanol treatment resulted in a significant increase in the cleavage and activity of caspase-3 in NCCs. SFN treatment significantly decreased the cleavage and activity of caspase-3 in ethanol-exposed NCCs, indicating that SFN can diminish ethanol-induced apoptosis in NCCs (Fig. 5A, B) . These results were further confirmed by the TUNEL assay, which showed that SFN can significantly reduce ethanol-induced apoptosis in NCCs (Fig. 5C ). These results demonstrate that ethanol can induce apoptosis in NCCs by increasing the HDAC activity, reducing the acetyl-histone H3 binding to Bcl-2 promoter and repressing Bcl-2 expression. SFN treatment can prevent ethanol-induced apoptosis in NCCs by epigenetically restoring the expression of the anti-apoptotic protein Bcl-2.
Treatment with SFN significantly diminished ethanol-induced apoptosis in mouse embryos
To further confirm that treatment with SFN can provide in vivo protection against ethanol-induced apoptosis in embryos, pregnant mice were given an i.p. injection of SFN at a dosage of 40 mg/kg body weight on GD 8:12, 12 h before the ethanol treatment. The mice were then administrated two i.p. doses of ethanol at a dosage of 1.9 g/kg on GD 9:0 and GD 9:4. As expected, in vivo ethanol exposure induced the activation of caspase-3, a marker for active apoptosis, in mouse embryos, as evidenced by a three-fold increase in the expression of cleaved caspase-3. Treatment with SFN resulted in a significant reduction in the activation of caspase-3 in ethanol-exposed mouse embryos, as compared with the group treated with ethanol alone (Fig. 6) . These results indicate that treatment with SFN is, indeed, effective in preventing apoptosis in mouse embryos exposed to ethanol in vivo. Fig. 2 . The expression of acetyl-Histone H3 in NCCs treated with SFN and ethanol. NCCs were exposed to 50 mM ethanol alone or pretreated with 1 μM SFN for 24 h, followed by 24 h of concurrent exposure to SFN and 50 mM ethanol. The expression of acetyl-histone H3, histone H3, and histone 2B was determined by western blot. Data are expressed as fold change over control and represent the mean ± SD of three separate experiments. *p < 0.05 vs. control; #p < 0.05 vs. ethanol. Fig. 3 . Effects of SFN on acetylated histone H3 binding to the Bcl-2 promoter in ethanolexposed NCCs. NCCs were exposed to 50 mM ethanol alone or pretreated with 1 μM SFN for 24 h, followed by 24 h of concurrent exposure to SFN and 50 mM ethanol. The binding of acetyl-histone H3 to the Bcl-2 promoter was measured by quantitative ChIP-qPCR assay with Acetyl-Histone H3 Immunoprecipitation Assay Kit as described in Method. Data are expressed as fold change over control and represent the mean ± SD of three separate experiments. *p < 0.05 vs. control; #p < 0.05 vs. ethanol.
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Discussion
Recent studies have shown that Nrf2-mediated antioxidant response is involved in the susceptibility of NCCs to ethanol-induced apoptosis and that SFN can prevent ethanol-induced apoptosis in NCCs by mediating the induction of Nrf2 signaling (Chen et al., 2013) . In this study, we found that exposure to ethanol resulted in a significant increase in HDAC activities in NCCs. Treatment with SFN decreased the activities of HDAC in ethanol-exposed NCCs. We also found that SFN treatment significantly increased the expression of acetyl-histone H3 in NCCs treated with ethanol. ChIP-qPCR assay revealed that ethanol exposure decreased acetyl-histone H3 binding to the Bcl-2 promoter while supplementing with SFN reversed the ethanol-induced reduction in acetylhistone H3 binding to the Bcl-2 promoter. In addition, SFN treatment restored the expression of Bcl-2 in ethanol-exposed NCCs and diminished ethanol-induced apoptosis. These results demonstrate that ethanol can induce apoptosis in NCCs by increasing the HDAC activity, reducing the acetyl-histone H3 binding to Bcl-2 promoter and repressing Bcl-2 expression. SFN can epigenetically restore the expression of Bcl-2 and attenuate ethanol-induced apoptosis by inhibiting HDAC activity and increasing histone acetylation at the Bcl-2 promoter. Treatment with SFN also significantly diminished apoptosis in mouse embryos exposed to ethanol in vivo.
HDACs play a crucial role in regulating the acetylation of histone and other proteins. Acetylation of histone can neutralize the positive charges on the histone complex and decrease its binding ability to DNA, Fig. 4 . Effects of SFN on the mRNA and protein expression of Bcl-2 in NCCs exposed to ethanol. NCCs were exposed to 50 mM ethanol alone or pretreated with 1 μM SFN for 24 h, followed by 24 h of concurrent exposure to SFN and 50 mM ethanol. The expression of Bcl-2 was determined by real-time PCR (A) or Western blotting (B), respectively. Data are expressed as fold change over control and represent the mean ± SD of three separate experiments. *p < 0.05 vs. control; #p < 0.05 vs. ethanol. Fig. 5 . Treatment with SFN attenuated ethanol-induced apoptosis in NCCs. NCCs were exposed to 50 mM ethanol alone or pretreated with 1 μM SFN for 24 h, followed by 24 h of concurrent exposure to SFN and 50 mM ethanol. Apoptosis was determined by the analysis of caspase-3 cleavage (A) and caspase activity assay (B) as well as the TUNEL assay (C). Data are expressed as fold change over control and represent the mean ± SD of three separate experiments. *p < 0.05 vs. control; #p < 0.05 vs. ethanol.
F. Yuan et al. Experimental Neurology 300 (2018) 60-66 which allows chromatin expansion and facilitates transcription (Zhu et al., 2001) . HDACs prevent transcription by removing the acetyl groups and increase the binding between histone complex and DNA (Marks et al., 2000) . The effects of ethanol treatment on HDAC activity have been investigated by a number of studies. While it has been reported that global HDAC activity was reduced after an acute ethanol injection (Botia et al., 2012) or binge ethanol administration (Kirpich et al., 2012) , and that ethanol treatment has no obvious effect on HDAC activity (Qiang et al., 2011; Perkins et al., 2013) , it has been demonstrated that ethanol exposure can result in a dose-dependent increase in HDAC2 expression in a human neuronal cell line (Agudelo et al., 2011) . Ethanol exposure also increased HDAC activity in neurons (Agudelo et al., 2012; Yao et al., 2013) . It is noteworthy that prenatal ethanol exposure has been found to be able to increase the HDAC activity in adult rat offspring (Yao et al., 2013; Yao and Nyomba, 2008) . This is consistent with our results that have shown that ethanol exposure resulted in a significant increase in HDAC activity in NCCs. Recently, HDACs have been implicated in cancer or other disorders and have become promising therapeutic targets with the potential to reverse or prevent the aberrant epigenetic states associated with a variety of disorders (Marks et al., 2001; Bonfils et al., 2008) (Chuang et al., 2009; Haberland et al., 2009) . With an increased appreciation of the importance of dietary factors in health and diseases, in addition to synthetic HDAC inhibitors, a growing number of dietary HDAC inhibitors have been identified, which include EGCG, curcumin, quercetin, butyrate and SFN (Myzak and Dashwood, 2006) . SFN is found at high levels in broccoli and other cruciferous vegetables and is metabolized to generate a number of intermediates with HDAC inhibitor activity. It has been reported that SFN inhibited HDAC activity and resulted in both global and localized histone hyperacetylation in human colon cancer cells (Myzak and Dashwood, 2006) . Supplementation of broccoli sprouts equated to 105 mg of SFN by human has also been shown to increase the acetylation of histones H3 and H4 in blood cells (Myzak et al., 2007) . In this study, we found that treatment with 1 μM SFN can effectively inhibit the ethanol-induced increase in HDAC activity in NCCs. Inhibition of HDAC by SFN also reversed the ethanolinduced decrease in the levels of acetylated histone H3 in NCCs.
The reversal of acetylation by HDACs associates with transcriptional repression, and the inhibition of HDACs results in hyperacetylation and upregulation of genes. In this study, we have demonstrated that ethanol-induced increased HDAC activity and decreased acetylation of histone H3 resulted in a reduction in the acetyl-histone H3 binding to the promoter of the anti-apoptotic gene, Bcl-2 in NCCs. This is consistent with the results from a recent study that has shown that ethanol exposure decreased the acetylation level of histone H3K9 in the promoter region of Bcl-2 (Yan et al., 2017) . We also found that supplementing with SFN significantly reduced the ethanol-induced reduction in acetyl-histone H3 binding to the Bcl-2 promoter and restored the mRNA and protein expression of Bcl-2 in NCCs treated with ethanol.
The Bcl-2 family proteins, including death antagonists (Bcl-2, Bcl-X L , etc.) and agonists (Bax, Bak, etc.) , play a vital role in regulating apoptosis (Danial and Korsmeyer, 2004) . It has been reported that prenatal ethanol exposure reduced cortical Bcl-2 expression (Mooney and Miller, 2001) . Studies have also shown that overexpression of Bcl-2 protects the neonatal cerebellum from ethanol-induced neurotoxicity (Heaton et al., 1999) . In this study, we have shown that ethanol exposure significantly decreased the mRNA and protein expression of Bcl-2, indicating that the ethanol-induced reduction in Bcl-2 expression is, at least in part, through increasing HDAC activity and reducing the acetyl-histone H3 binding to the Bcl-2 promoter. We have also shown that SFN co-treatment can restore the expression of Bcl-2 by increasing the acetyl-histone H3 binding to the Bcl-2 promoter and prevent ethanol-induced apoptosis in NCCs and mouse embryos. These results suggest that SFN can prevent ethanol-induced apoptosis through epigenetic regulation of the expression of anti-apoptotic genes.
In conclusion, the results of the current study demonstrate that ethanol exposure can induce apoptosis in NCCs through increasing HDAC activity, reducing the acetyl-histoneH3 binding to the Bcl-2 promoter and repressing Bcl-2 expression. SFN, a potent dietary HDAC inhibitor, can epigenetically restore the expression of Bcl-2 and attenuate ethanol-induced apoptosis by inhibiting HDAC activity and increasing histone acetylation at the Bcl-2 promoter. These findings provide insights into the epigenetic mechanisms involved in the induction of apoptosis in ethanol-exposed embryonic cells. In addition, the potency of SFN in restoring anti-apoptotic gene and preventing ethanol-induced apoptosis in NCCs and mouse embryos, along with the fact that SFN is a bioactive compound derived from broccoli and other cruciferous vegetables, illustrates the potential of a practical and promising nutraceutical-based therapeutic strategy for human FASD.
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The authors declare that they have no conflicts of interest with the contents of this article. Fig. 6 . Co-treatment with SFN significantly diminished ethanol-induced apoptosis in mouse embryos. Pregnant mice were given an i.p. injection of SFN at a dosage of 40 mg/ kg maternal body weight or PBS on GD 8:12 and then were given two i.p. doses of ethanol at a dosage of 1.9 g/kg maternal body weight on GD 9:0 and 9:4. Pregnant mice were killed by cervical dislocation on GD 9:12 and the embryos were collected for protein preparation. Apoptosis was determined by analysis of caspase-3 activation by Western blot. Data are expressed as fold change over control and represent the mean ± SD of three separate experiments. *p < 0.05 vs. control.
